Intratumoral Tcf1+PD-1+cd8+ T Cells With Stem-Like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Immunity - United States
doi 10.1016/j.immuni.2018.12.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

OX40 Agonist Immunotherapy Expands Tumor Reactive CD8 T Cells With a Unique T Cell Receptor Repertoire and Synergizes With PDL-1 Blockade to Promote Tumor Regression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells With Stem Cell-Like Properties

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Epitherapy and Immune Checkpoint Blockade: Using Epigenetic Reinvigoration of Exhausted and Dysfunctional T Cells to Reimburse Immunotherapy Response

BMC Immunology
Immunology
2020English

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Cancer Research
Cancer ResearchOncology
2015English

Long-Lasting Stem Cell-Like Memory CD8+ T Cells With a Naive-Like Profile Upon Yellow Fever Vaccination

Science Translational Medicine
Medicine
2015English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Prediction of Clinical Response to Checkpoint Blockade Immunotherapy Is Improved With Ensembling

2019English

PD-L1 Expression in Basaloid Squamous Cell Lung Carcinoma: Relationship to PD-1+ and CD8+ Tumor-Infiltrating T Cells and Outcome

Modern Pathology
Forensic MedicinePathology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy